Why the study?
Does defective G protein activation explain the inability of fenoldopam to buffer Ang-II-induced renal vasoconstriction in spontaneously hypertensive rats?
Does defective G protein activation explain the inability of fenoldopam to buffer Ang-II-induced renal vasoconstriction in spontaneously hypertensive rats?
The study demonstrates that a defective interaction between receptor coupling and Gs protein activation in the renal microcirculation contributes to exaggerated angiotensin II-induced vasoconstriction in genetic hypertension.
Answers are grounded in this paper and cite their sources.
Remains preclinical only; leaves open whether Gs protein defects drive human Ang-II renal vasoconstriction.
The development of hypertension in the spontaneously hypertensive rat (SHR) is associated with renal dysfunction and vasoconstriction. The kidneys of young SHRs exhibit exaggerated reactivity to angiotensin II (Ang-II) and attenuated responses to vasodilators that normally activate the cAMP signal to buffer hormone-induced vasoconstriction. The present study investigates the mechanism(s) responsible for this abnormality in activation of the cAMP second-messenger pathway in hypertensive animals. Renal vascular reactivity was assessed in 7-week-old anesthetized SHRs and normotensive Wistar-Kyoto rats. The animals were pretreated with indomethacin to block prostanoid production throughout an experiment. Ang-II was injected into the renal artery either alone or mixed with the vasodilator fenoldopam, a dopamine-receptor agonist. These two opposing vasoactive agents were administered before and during intrarenal infusion of NaF or cholera toxin, two activators of G proteins that stimulate cAMP production. The results show that Ang-II reduced renal blood flow by 45% in both strains. In Wistar-Kyoto rats, fenoldopam reduced the Ang-II-induced decrease in renal blood flow from -45% to -30%. This protective effect of fenoldopam was increased further during infusion of NaF or cholera toxin (-18% or -19% decrease in renal blood flow). In SHRs, fenoldopam failed to attenuate Ang II-mediated vasoconstriction (-45% vs. -44%). In contrast, fenoldopam effectively blunted the Ang-II-induced vasoconstriction when it was given concurrently with NaF or cholera toxin (-27 or -31% decrease in renal blood flow). These findings provide evidence for defective interaction between receptor coupling and activation of guanine nucleotide stimulatory factor proteins in the renal microcirculation of 7-week-old SHRs. Such a deficiency could play an important role in renal dysfunction associated with the development of genetic hypertension.
No takes yet. Share an insight, caveat, or question.
Chatziantoniou et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: